Share Price and Basic Stock Data
Last Updated: November 28, 2025, 8:34 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kanoria Chemicals & Industries Ltd operates in the organic chemicals sector, specifically focusing on alcohol-based products. The company’s stock price stood at ₹76.3, with a market capitalization of ₹333 Cr. Over the years, Kanoria has experienced fluctuations in revenue, with sales recorded at ₹1,578 Cr in FY 2023, a notable increase from ₹1,369 Cr in FY 2022. However, the company reported a decline in sales for FY 2024, which stood at ₹1,475 Cr, before rebounding slightly to ₹1,537 Cr in FY 2025. The quarterly sales figures also reflect variability, with the highest sales of ₹445 Cr occurring in Mar 2023 and a subsequent drop to ₹371 Cr by Sep 2023. This inconsistent revenue performance may indicate challenges in maintaining market demand or operational efficiency. Despite this, the trailing twelve-month (TTM) revenue was ₹1,190 Cr, suggesting an overall downward trend compared to previous fiscal years.
Profitability and Efficiency Metrics
Kanoria Chemicals’ profitability has been under pressure, as evidenced by its operating profit margin (OPM) of only 4% for the current fiscal year. The operating profit reported in FY 2025 was ₹31 Cr, significantly lower than the ₹72 Cr recorded in FY 2023. The company’s net profit margin turned negative, with a net loss of ₹108 Cr for FY 2025, compared to a loss of ₹13 Cr in FY 2023. The interest coverage ratio (ICR) stood at 0.88x, indicating potential difficulties in covering interest expenses with operating income. Efficiency metrics reveal a cash conversion cycle of 63 days, which is moderate, yet the return on equity (ROE) has declined to -16.05% in FY 2025 from 1.14% in FY 2022, signaling deteriorating shareholder returns. This combination of low margins and declining profitability raises concerns about the company’s operational efficiency and financial health.
Balance Sheet Strength and Financial Ratios
As of FY 2025, Kanoria Chemicals reported total borrowings of ₹595 Cr against reserves of ₹499 Cr, reflecting a debt-to-equity ratio of 1.14x. This high leverage could pose risks, especially given the company’s negative net income. The current ratio was recorded at 0.99, indicating that current liabilities nearly match current assets, which could lead to liquidity pressures. The book value per share declined to ₹119.19 in FY 2025 from ₹141.33 in FY 2024, suggesting a decrease in shareholder equity. The company has also seen a significant increase in total liabilities, rising to ₹1,498 Cr, which may limit financial flexibility. Additionally, the price-to-book value ratio stood at 0.62x, indicating that the market values the company below its book value, a potential sign of investor skepticism regarding future growth prospects.
Shareholding Pattern and Investor Confidence
Kanoria Chemicals has a stable shareholding pattern, with promoters holding 74.39% of the shares, which indicates a strong commitment from the founding family. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) held marginal stakes of 0.04% and 0.08%, respectively, reflecting limited institutional interest. The total number of shareholders increased to 17,555 by Mar 2025, suggesting growing retail investor participation. Despite the high promoter holding, the low institutional interest may raise concerns about the company’s attractiveness to larger investors. The public shareholding has remained relatively stable, fluctuating around 25.46%. This stability, combined with the significant promoter stake, may provide some reassurance for retail investors, but the overall lack of institutional backing could hinder the stock’s potential for upward momentum.
Outlook, Risks, and Final Insight
Looking ahead, Kanoria Chemicals faces several significant risks, including declining profitability and high leverage, which could impact its ability to sustain operations and invest in growth initiatives. The company’s inconsistent revenue trends and negative net profit margins pose challenges, particularly in a competitive chemicals market. However, strengths such as a strong promoter backing and a relatively stable shareholder base may provide a buffer against market volatility. To regain investor confidence, the company will need to implement strategies focused on improving operational efficiency and enhancing profitability. If it can successfully navigate these challenges, Kanoria Chemicals could stabilize its financial position and potentially return to a growth trajectory. Conversely, failure to address these issues may lead to further declines in financial health and shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Kanoria Chemicals & Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aeonx Digital Technology Ltd | 88.3 Cr. | 192 | 323/121 | 29.4 | 115 | 0.52 % | 9.78 % | 6.79 % | 10.0 |
| Kanoria Chemicals & Industries Ltd | 329 Cr. | 75.6 | 127/71.0 | 122 | 0.00 % | 2.33 % | 11.8 % | 5.00 | |
| India Glycols Ltd | 7,274 Cr. | 1,084 | 1,223/502 | 28.1 | 387 | 0.46 % | 12.4 % | 11.1 % | 5.00 |
| Industry Average | 3,801.50 Cr | 450.53 | 28.75 | 208.00 | 0.33% | 8.17% | 9.90% | 6.67 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 386 | 362 | 385 | 445 | 401 | 371 | 342 | 361 | 384 | 374 | 348 | 431 | 454 |
| Expenses | 360 | 356 | 369 | 422 | 391 | 365 | 339 | 333 | 382 | 361 | 348 | 414 | 437 |
| Operating Profit | 27 | 6 | 17 | 23 | 10 | 6 | 3 | 29 | 2 | 13 | -0 | 17 | 16 |
| OPM % | 7% | 2% | 4% | 5% | 3% | 2% | 1% | 8% | 0% | 3% | -0% | 4% | 4% |
| Other Income | 7 | -0 | 3 | -0 | 13 | -0 | 8 | 0 | 2 | 5 | 1 | -27 | 1 |
| Interest | 7 | 8 | 10 | 11 | 11 | 12 | 9 | 12 | 11 | 12 | 11 | 12 | 11 |
| Depreciation | 14 | 14 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 | 16 | 17 |
| Profit before tax | 12 | -17 | -5 | -3 | -2 | -21 | -13 | 2 | -22 | -9 | -27 | -38 | -10 |
| Tax % | 30% | -1% | -14% | -70% | 67% | -3% | 14% | 816% | 4% | 76% | 6% | 5% | 32% |
| Net Profit | 9 | -17 | -4 | -1 | -4 | -21 | -15 | -16 | -23 | -16 | -29 | -40 | -14 |
| EPS in Rs | 1.89 | -3.26 | -0.29 | -0.35 | -0.60 | -4.20 | -1.86 | -2.12 | -3.81 | -3.18 | -3.82 | -8.33 | -1.79 |
Last Updated: August 20, 2025, 8:20 am
Below is a detailed analysis of the quarterly data for Kanoria Chemicals & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 454.00 Cr.. The value appears strong and on an upward trend. It has increased from 431.00 Cr. (Mar 2025) to 454.00 Cr., marking an increase of 23.00 Cr..
- For Expenses, as of Jun 2025, the value is 437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 414.00 Cr. (Mar 2025) to 437.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Jun 2025, the value is 4.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00%.
- For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from -27.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 28.00 Cr..
- For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -10.00 Cr.. The value appears strong and on an upward trend. It has increased from -38.00 Cr. (Mar 2025) to -10.00 Cr., marking an increase of 28.00 Cr..
- For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from 5.00% (Mar 2025) to 32.00%, marking an increase of 27.00%.
- For Net Profit, as of Jun 2025, the value is -14.00 Cr.. The value appears strong and on an upward trend. It has increased from -40.00 Cr. (Mar 2025) to -14.00 Cr., marking an increase of 26.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.79. The value appears strong and on an upward trend. It has increased from -8.33 (Mar 2025) to -1.79, marking an increase of 6.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:02 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 541 | 531 | 565 | 702 | 837 | 1,072 | 1,005 | 1,095 | 1,369 | 1,578 | 1,475 | 1,537 | 1,190 |
| Expenses | 500 | 506 | 533 | 675 | 802 | 1,008 | 977 | 1,001 | 1,301 | 1,506 | 1,423 | 1,505 | 1,149 |
| Operating Profit | 41 | 25 | 32 | 27 | 35 | 64 | 28 | 94 | 68 | 72 | 52 | 31 | 41 |
| OPM % | 8% | 5% | 6% | 4% | 4% | 6% | 3% | 9% | 5% | 5% | 4% | 2% | 3% |
| Other Income | 43 | 27 | 15 | 7 | 45 | 7 | 22 | 8 | 29 | 10 | 16 | -19 | 67 |
| Interest | 17 | 9 | 14 | 20 | 24 | 36 | 37 | 32 | 27 | 36 | 43 | 46 | 39 |
| Depreciation | 24 | 30 | 34 | 45 | 47 | 49 | 56 | 58 | 57 | 59 | 59 | 63 | 50 |
| Profit before tax | 43 | 13 | -1 | -32 | 10 | -15 | -43 | 11 | 13 | -12 | -34 | -96 | 20 |
| Tax % | 20% | 7% | 414% | -25% | -20% | 30% | -26% | -40% | 83% | 5% | 61% | 12% | |
| Net Profit | 34 | 12 | -7 | -24 | 12 | -20 | -32 | 16 | 2 | -13 | -55 | -108 | 9 |
| EPS in Rs | 7.72 | 2.82 | -1.65 | -3.38 | 3.22 | -3.42 | -5.90 | 3.32 | 1.56 | -2.01 | -8.79 | -19.13 | 7.45 |
| Dividend Payout % | 19% | 53% | -91% | -44% | 47% | -22% | 0% | 0% | 64% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -64.71% | -158.33% | -242.86% | 150.00% | -266.67% | -60.00% | 150.00% | -87.50% | -750.00% | -323.08% | -96.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | -93.63% | -84.52% | 392.86% | -416.67% | 206.67% | 210.00% | -237.50% | -662.50% | 426.92% | 226.71% |
Kanoria Chemicals & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 16% |
| 3 Years: | -20% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -3% |
| 3 Years: | -7% |
| Last Year: | -11% |
Last Updated: September 5, 2025, 8:50 am
Balance Sheet
Last Updated: October 10, 2025, 2:22 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 474 | 472 | 581 | 558 | 566 | 577 | 547 | 565 | 577 | 584 | 579 | 499 |
| Borrowings | 161 | 331 | 430 | 408 | 440 | 509 | 539 | 493 | 475 | 510 | 509 | 595 |
| Other Liabilities | 152 | 157 | 192 | 222 | 250 | 293 | 266 | 282 | 329 | 366 | 380 | 382 |
| Total Liabilities | 810 | 982 | 1,225 | 1,209 | 1,278 | 1,401 | 1,374 | 1,362 | 1,403 | 1,481 | 1,490 | 1,498 |
| Fixed Assets | 328 | 344 | 512 | 743 | 800 | 850 | 894 | 864 | 863 | 882 | 850 | 865 |
| CWIP | 14 | 182 | 269 | 27 | 12 | 42 | 15 | 14 | 10 | 10 | 47 | 46 |
| Investments | 211 | 174 | 138 | 100 | 63 | 48 | 26 | 19 | 22 | 17 | 16 | 14 |
| Other Assets | 257 | 282 | 306 | 340 | 403 | 461 | 439 | 465 | 507 | 573 | 578 | 574 |
| Total Assets | 810 | 982 | 1,225 | 1,209 | 1,278 | 1,401 | 1,374 | 1,362 | 1,403 | 1,481 | 1,490 | 1,498 |
Below is a detailed analysis of the balance sheet data for Kanoria Chemicals & Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
- For Reserves, as of Mar 2025, the value is 499.00 Cr.. The value appears to be declining and may need further review. It has decreased from 579.00 Cr. (Mar 2024) to 499.00 Cr., marking a decrease of 80.00 Cr..
- For Borrowings, as of Mar 2025, the value is 595.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 509.00 Cr. (Mar 2024) to 595.00 Cr., marking an increase of 86.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 382.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 380.00 Cr. (Mar 2024) to 382.00 Cr., marking an increase of 2.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,498.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,490.00 Cr. (Mar 2024) to 1,498.00 Cr., marking an increase of 8.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 865.00 Cr.. The value appears strong and on an upward trend. It has increased from 850.00 Cr. (Mar 2024) to 865.00 Cr., marking an increase of 15.00 Cr..
- For CWIP, as of Mar 2025, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2024) to 46.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Other Assets, as of Mar 2025, the value is 574.00 Cr.. The value appears to be declining and may need further review. It has decreased from 578.00 Cr. (Mar 2024) to 574.00 Cr., marking a decrease of 4.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,498.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,490.00 Cr. (Mar 2024) to 1,498.00 Cr., marking an increase of 8.00 Cr..
However, the Borrowings (595.00 Cr.) are higher than the Reserves (499.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -120.00 | -306.00 | -398.00 | -381.00 | -405.00 | -445.00 | -511.00 | -399.00 | -407.00 | -438.00 | -457.00 | -564.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 51 | 57 | 59 | 60 | 50 | 52 | 68 | 46 | 45 | 46 | 56 |
| Inventory Days | 101 | 82 | 86 | 87 | 92 | 96 | 97 | 84 | 97 | 91 | 104 | 84 |
| Days Payable | 77 | 66 | 53 | 77 | 84 | 74 | 85 | 77 | 80 | 75 | 82 | 78 |
| Cash Conversion Cycle | 82 | 68 | 89 | 69 | 68 | 71 | 64 | 75 | 63 | 61 | 68 | 63 |
| Working Capital Days | 43 | -7 | -8 | -5 | -8 | -2 | -7 | 16 | 17 | 8 | 9 | -4 |
| ROCE % | 5% | 1% | 1% | 1% | 3% | 2% | -1% | 4% | 4% | 1% | 1% | -2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| Diluted EPS (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| Cash EPS (Rs.) | -10.42 | 1.65 | 10.54 | 13.60 | 16.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.19 | 141.33 | 138.93 | 137.75 | 136.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.19 | 141.33 | 138.93 | 137.75 | 136.25 |
| Revenue From Operations / Share (Rs.) | 351.67 | 337.94 | 361.21 | 313.31 | 250.55 |
| PBDIT / Share (Rs.) | 9.29 | 16.47 | 18.92 | 22.20 | 24.16 |
| PBIT / Share (Rs.) | -5.04 | 2.17 | 5.44 | 9.11 | 10.88 |
| PBT / Share (Rs.) | -22.26 | -8.23 | -2.79 | 3.01 | 2.61 |
| Net Profit / Share (Rs.) | -24.75 | -12.65 | -2.95 | 0.51 | 3.66 |
| NP After MI And SOA / Share (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| PBDIT Margin (%) | 2.64 | 4.87 | 5.23 | 7.08 | 9.64 |
| PBIT Margin (%) | -1.43 | 0.64 | 1.50 | 2.90 | 4.34 |
| PBT Margin (%) | -6.32 | -2.43 | -0.77 | 0.95 | 1.04 |
| Net Profit Margin (%) | -7.03 | -3.74 | -0.81 | 0.16 | 1.46 |
| NP After MI And SOA Margin (%) | -5.43 | -2.60 | -0.55 | 0.49 | 1.32 |
| Return on Networth / Equity (%) | -16.05 | -6.38 | -1.44 | 1.14 | 2.47 |
| Return on Capital Employeed (%) | -2.37 | 0.96 | 2.44 | 4.00 | 4.81 |
| Return On Assets (%) | -5.57 | -2.57 | -0.59 | 0.48 | 1.06 |
| Long Term Debt / Equity (X) | 0.65 | 0.49 | 0.52 | 0.57 | 0.58 |
| Total Debt / Equity (X) | 1.14 | 0.84 | 0.83 | 0.78 | 0.78 |
| Asset Turnover Ratio (%) | 1.03 | 0.99 | 1.09 | 0.57 | 0.34 |
| Current Ratio (X) | 0.99 | 1.11 | 1.12 | 1.24 | 1.22 |
| Quick Ratio (X) | 0.56 | 0.54 | 0.57 | 0.61 | 0.77 |
| Inventory Turnover Ratio (X) | 5.79 | 3.51 | 4.30 | 4.34 | 2.28 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | -49.84 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 8.70 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 149.84 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 91.30 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.88 | 1.67 | 2.30 | 3.64 | 3.27 |
| Interest Coverage Ratio (Post Tax) (X) | -0.73 | -0.22 | 0.64 | 1.08 | 1.61 |
| Enterprise Value (Cr.) | 900.35 | 972.38 | 951.81 | 1045.87 | 835.26 |
| EV / Net Operating Revenue (X) | 0.58 | 0.65 | 0.60 | 0.76 | 0.76 |
| EV / EBITDA (X) | 22.19 | 13.51 | 11.51 | 10.78 | 7.91 |
| MarketCap / Net Operating Revenue (X) | 0.21 | 0.31 | 0.29 | 0.43 | 0.36 |
| Retention Ratios (%) | 0.00 | 0.00 | 149.84 | 0.00 | 0.00 |
| Price / BV (X) | 0.62 | 0.76 | 0.76 | 0.99 | 0.67 |
| Price / Net Operating Revenue (X) | 0.21 | 0.31 | 0.29 | 0.43 | 0.36 |
| EarningsYield | -0.25 | -0.08 | -0.01 | 0.01 | 0.03 |
After reviewing the key financial ratios for Kanoria Chemicals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 5. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 5. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For Cash EPS (Rs.), as of Mar 25, the value is -10.42. This value is below the healthy minimum of 3. It has decreased from 1.65 (Mar 24) to -10.42, marking a decrease of 12.07.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.19. It has decreased from 141.33 (Mar 24) to 119.19, marking a decrease of 22.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.19. It has decreased from 141.33 (Mar 24) to 119.19, marking a decrease of 22.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 351.67. It has increased from 337.94 (Mar 24) to 351.67, marking an increase of 13.73.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 16.47 (Mar 24) to 9.29, marking a decrease of 7.18.
- For PBIT / Share (Rs.), as of Mar 25, the value is -5.04. This value is below the healthy minimum of 0. It has decreased from 2.17 (Mar 24) to -5.04, marking a decrease of 7.21.
- For PBT / Share (Rs.), as of Mar 25, the value is -22.26. This value is below the healthy minimum of 0. It has decreased from -8.23 (Mar 24) to -22.26, marking a decrease of 14.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -24.75. This value is below the healthy minimum of 2. It has decreased from -12.65 (Mar 24) to -24.75, marking a decrease of 12.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 2. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For PBDIT Margin (%), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 10. It has decreased from 4.87 (Mar 24) to 2.64, marking a decrease of 2.23.
- For PBIT Margin (%), as of Mar 25, the value is -1.43. This value is below the healthy minimum of 10. It has decreased from 0.64 (Mar 24) to -1.43, marking a decrease of 2.07.
- For PBT Margin (%), as of Mar 25, the value is -6.32. This value is below the healthy minimum of 10. It has decreased from -2.43 (Mar 24) to -6.32, marking a decrease of 3.89.
- For Net Profit Margin (%), as of Mar 25, the value is -7.03. This value is below the healthy minimum of 5. It has decreased from -3.74 (Mar 24) to -7.03, marking a decrease of 3.29.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 8. It has decreased from -2.60 (Mar 24) to -5.43, marking a decrease of 2.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is -16.05. This value is below the healthy minimum of 15. It has decreased from -6.38 (Mar 24) to -16.05, marking a decrease of 9.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.37. This value is below the healthy minimum of 10. It has decreased from 0.96 (Mar 24) to -2.37, marking a decrease of 3.33.
- For Return On Assets (%), as of Mar 25, the value is -5.57. This value is below the healthy minimum of 5. It has decreased from -2.57 (Mar 24) to -5.57, marking a decrease of 3.00.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.49 (Mar 24) to 0.65, marking an increase of 0.16.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has increased from 0.99 (Mar 24) to 1.03, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1.5. It has decreased from 1.11 (Mar 24) to 0.99, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.56, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.79. This value is within the healthy range. It has increased from 3.51 (Mar 24) to 5.79, marking an increase of 2.28.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 3. It has decreased from 1.67 (Mar 24) to 0.88, marking a decrease of 0.79.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.73. This value is below the healthy minimum of 3. It has decreased from -0.22 (Mar 24) to -0.73, marking a decrease of 0.51.
- For Enterprise Value (Cr.), as of Mar 25, the value is 900.35. It has decreased from 972.38 (Mar 24) to 900.35, marking a decrease of 72.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.58, marking a decrease of 0.07.
- For EV / EBITDA (X), as of Mar 25, the value is 22.19. This value exceeds the healthy maximum of 15. It has increased from 13.51 (Mar 24) to 22.19, marking an increase of 8.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.31 (Mar 24) to 0.21, marking a decrease of 0.10.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.62, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.31 (Mar 24) to 0.21, marking a decrease of 0.10.
- For EarningsYield, as of Mar 25, the value is -0.25. This value is below the healthy minimum of 5. It has decreased from -0.08 (Mar 24) to -0.25, marking a decrease of 0.17.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kanoria Chemicals & Industries Ltd:
- Net Profit Margin: -7.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.37% (Industry Average ROCE: 8.17%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -16.05% (Industry Average ROE: 9.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.73
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 28.75)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.14
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Alcohol Based | KCI Plaza, 6th Floor, Kolkata West Bengal 700019 | info@kanoriachem.com http://www.kanoriachem.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R V Kanoria | Chairman & Managing Director |
| Mr. S V Kanoria | Whole Time Director |
| Mr. H K Khaitan | Non Exe.Non Ind.Director |
| Mrs. Madhuvanti Kanoria | Non Exe.Non Ind.Director |
| Mr. Sidharth Kumar Birla | Ind. Non-Executive Director |
| Mrs. Suhana Murshed | Ind. Non-Executive Director |
| Mrs. Meeta Makhan | Ind. Non-Executive Director |
| Mr. Sumanta Chaudhuri | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Kanoria Chemicals & Industries Ltd?
Kanoria Chemicals & Industries Ltd's intrinsic value (as of 01 December 2025) is 176.21 which is 133.08% higher the current market price of 75.60, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 329 Cr. market cap, FY2025-2026 high/low of 127/71.0, reserves of ₹499 Cr, and liabilities of 1,498 Cr.
What is the Market Cap of Kanoria Chemicals & Industries Ltd?
The Market Cap of Kanoria Chemicals & Industries Ltd is 329 Cr..
What is the current Stock Price of Kanoria Chemicals & Industries Ltd as on 01 December 2025?
The current stock price of Kanoria Chemicals & Industries Ltd as on 01 December 2025 is 75.6.
What is the High / Low of Kanoria Chemicals & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kanoria Chemicals & Industries Ltd stocks is 127/71.0.
What is the Stock P/E of Kanoria Chemicals & Industries Ltd?
The Stock P/E of Kanoria Chemicals & Industries Ltd is .
What is the Book Value of Kanoria Chemicals & Industries Ltd?
The Book Value of Kanoria Chemicals & Industries Ltd is 122.
What is the Dividend Yield of Kanoria Chemicals & Industries Ltd?
The Dividend Yield of Kanoria Chemicals & Industries Ltd is 0.00 %.
What is the ROCE of Kanoria Chemicals & Industries Ltd?
The ROCE of Kanoria Chemicals & Industries Ltd is 2.33 %.
What is the ROE of Kanoria Chemicals & Industries Ltd?
The ROE of Kanoria Chemicals & Industries Ltd is 11.8 %.
What is the Face Value of Kanoria Chemicals & Industries Ltd?
The Face Value of Kanoria Chemicals & Industries Ltd is 5.00.